# Canine MPV17 truncation without clinical manifestations

**Authors:** Reetta L. Hänninen, Saija Ahonen, Merce Màrquez, Maarit J. Myöhänen, Marjo K. Hytönen, Hannes Lohi

PMC · DOI: 10.1242/bio.013870 · 2015-09-09

## TL;DR

A MPV17 gene mutation in dogs causes protein truncation but no obvious health issues, suggesting species differences in disease manifestation.

## Contribution

Identifies a MPV17 truncation mutation in dogs with no clinical symptoms, establishing a new large animal model for mitochondrial research.

## Key findings

- A 1-bp insertion in MPV17 exon 4 causes frameshift and protein truncation in dogs.
- MPV17 expression is reduced in homozygous dogs, and the truncated protein is not translated in transfected cells.
- No common phenotypes are observed in affected dogs, despite the mutation being highly enriched in Boxers.

## Abstract

Mitochondrial DNA depletion syndromes (MDS) are often serious autosomal recessively inherited disorders characterized by tissue-specific mtDNA copy number reduction. Many genes, including MPV17, are associated with the hepatocerebral form of MDS. MPV17 encodes for a mitochondrial inner membrane protein with a poorly characterized function. Several MPV17 mutations have been reported in association with a heterogeneous group of early-onset manifestations, including liver disease and neurological problems. Mpv17-deficient mice present renal and hearing defects. We describe here a MPV17 truncation mutation in dogs. We found a 1-bp insertion in exon 4 of the MPV17 gene, resulting in a frameshift and early truncation of the encoded protein. The mutation halves MPV17 expression in the lymphocytes of the homozygous dogs and the truncated protein is not translated in transfected cells. The insertion mutation is recurrent and exists in many unrelated breeds, although is highly enriched in the Boxer breed. Unexpectedly, despite the truncation of MPV17, we could not find any common phenotypes in the genetically affected dogs. The lack of observable phenotype could be due to a late onset, mild symptoms or potential tissue-specific compensatory mechanisms. This study suggests species-specific differences in the manifestation of the MPV17 defects and establishes a novel large animal model to further study MPV17 function and role in mitochondrial biology.

## Linked entities

- **Genes:** MPV17 (mitochondrial inner membrane protein MPV17) [NCBI Gene 4358]
- **Proteins:** MPV17 (mitochondrial inner membrane protein MPV17)
- **Diseases:** liver disease (MONDO:0005154)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Mpv17 (MpV17 mitochondrial inner membrane protein) [NCBI Gene 17527] {aka Tg.Mpv17}, TK2 (thymidine kinase 2) [NCBI Gene 611387], POLG2 (DNA polymerase gamma 2, accessory subunit) [NCBI Gene 490910], OPA1 (OPA1 mitochondrial dynamin like GTPase) [NCBI Gene 477129], Tomm40 (translocase of outer mitochondrial membrane 40) [NCBI Gene 53333] {aka Mom35, Tom40}, mpv17 (mitochondrial inner membrane protein MPV17) [NCBI Gene 394140] {aka roy, zgc:63573}, MPV17 (mitochondrial inner membrane protein MPV17) [NCBI Gene 4358] {aka CMT2EE, MTDPS6, SYM1}, TWNK (twinkle mtDNA helicase) [NCBI Gene 486845] {aka C28H10orf2, PEO1}, RRM2B (ribonucleotide reductase regulatory TP53 inducible subunit M2B) [NCBI Gene 481988], SUCLA2 (succinate-CoA ligase ADP-forming subunit beta) [NCBI Gene 485448] {aka A-SCS, SCS-betaA}, MPV17 (mitochondrial inner membrane protein MPV17) [NCBI Gene 611056], DGUOK (deoxyguanosine kinase) [NCBI Gene 475791], B2M [NCBI Gene 478284], PMP22 (peripheral myelin protein 22) [NCBI Gene 479509], SUCLG1 (succinate-CoA ligase GDP/ADP-forming subunit alpha) [NCBI Gene 475775], SLC25A4 (solute carrier family 25 member 4) [NCBI Gene 475630]
- **Diseases:** renal failure (MESH:D051437), renal and hearing defects (MESH:C536586), leukoencephalopathy (MESH:D056784), encephalomyopathic (OMIM:615471), liver failure (MESH:D017093), organ failure (MESH:D009102), autosomal recessively inherited disorders (MESH:D030342), cancers (MESH:D009369), liver disease (MESH:D008107), renal and auditory defects (MESH:C537754), dysfunction of oxidative phosphorylation system (MESH:D028361), hepatocerebral MDS (OMIM:251880), neuropathy (MESH:D009422), myopathic (MESH:D009135), pigmentation (MESH:D010859), degenerative myelopathy (MESH:D019636), hepatocerebral (MESH:D006501), deafness (MESH:D003638), neurological problems (MESH:D009461), spinal gangliopathy (MESH:D013122), kidney disease (MESH:D007674), MDS (MESH:C536350), heart disorders (MESH:D006331), hereditary sensitive neuropathy (MESH:D009386), vertebral column alterations (MESH:C536342), spondylosis (MESH:D055009)
- **Species:** Bos taurus (bovine, species) [taxon 9913], Danio rerio (leopard danio, species) [taxon 7955], Macaca mulatta (rhesus macaque, species) [taxon 9544], Homo sapiens (human, species) [taxon 9606], Canis lupus familiaris (dog, subspecies) [taxon 9615], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** p.F96LfsX43, c.279insG
- **Cell lines:** fibroblasts — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), MEF — Mus musculus (Mouse), Finite cell line (CVCL_9115), -puro — Homo sapiens (Human), Transformed cell line (CVCL_JZ02)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4610228/full.md

---
Source: https://tomesphere.com/paper/PMC4610228